We examined S100A8, IL-6, IL-6R, IL-8, and CXCL3 genes; each of these are known to be differentially expressed in breast cancer and are being evaluated as biomarkers and therapeutic targets [56,57,58,59,60]. This evidence concerns the gene CXCL3 and breast carcinoma.